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Asthma self-management education in persons with work-
related asthma – United States, 2012–2014
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Abstract
Objective: According to the National Asthma Education and Prevention Program (NAEPP), self-
management education is an integral component of effective asthma care and should be offered to 
every patient with asthma. To estimate the proportion of persons with work-related asthma (WRA) 
who received asthma self-management education.
Methods: A cross-sectional analysis of 2012–2014 Behavioral Risk Factor Surveillance System 
Asthma Call-back Survey data was conducted among ever-employed adults (≥18 years) with 
current asthma from 31 states and the District of Columbia.
Results: Adults with WRA were significantly more likely than those with non-WRA to have ever 
taken a course to manage their asthma (15.7% versus 6.5%; PR = 2.1), been given an asthma 
action plan (43.5% versus 26.1%; PR = 1.7), shown how to use an inhaler (97.2% versus 95.8%; 
PR = 1.0), taught how to recognize early symptoms of an asthma episode (79.4% versus 64.1%; 
PR = 1.2), taught what to do during an asthma episode (86.4% versus 76.3%; PR = 1.1), taught 
how to use a peak flow meter to adjust daily medications (57.9% versus 41.7%; PR = 1.3), and 
advised to change things in home, school, or work (56.9% versus 30.4%; PR = 2.0). Moreover, 
targets for corresponding Healthy People 2020 respiratory disease objectives were met only among 
adults with WRA.
Conclusions: Although adults with WRA were more likely to have received asthma self-
management education, results suggest missed opportunities to provide asthma self-management 
education. Every healthcare visit should be used as an opportunity to discuss asthma self-
management.
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Introduction
Self-management education is one of four key components of effective asthma care 
recommended by the National Asthma Education and Prevention Program (NAEPP) and 
should be offered to every patient with asthma at all points of care (1). Moreover, a Healthy 
People 2020 respiratory disease objective focuses on increasing the proportion of persons 
who receive appropriate asthma self-management education according to the NAEPP 
guidelines (1,2). Evidence suggests that asthma self-management education is effective in 
improving asthma control, reducing exacerbations and healthcare utilization, and improving 
quality of life (3). Nonetheless, some adults with asthma are not receiving recommended 
asthma self-management education (4). Persons with asthma caused or worsened by 
workplace exposures (i.e., work-related asthma [WRA]) have more frequent and severe 
asthma symptoms and greater asthma-related healthcare utilization than those with non-
WRA (5,6). Proper education and management of WRA are important and may reduce 
exacerbations, decrease use of medical resources, and help patients anticipate and respond to 
symptoms in relation to their work environment (5–8).
Selected topic areas of the NAEPP guidelines are currently under revision (9,10). Moreover, 
to our knowledge, there is no population-based information available on receipt of asthma 
self-management education in persons with WRA. Therefore, to inform new guidelines and 
future studies, the objective of the study was to estimate the proportion of persons who 
received asthma self-management education, stratified by WRA status, using the most 
currently available Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back 
Survey (ACBS) data (2012–2014) for ever-employed adults with current asthma from 31 
states and the District of Columbia (DC). Additionally, we examined factors associated with 
receiving asthma self-management education among persons with WRA.
Methods
BRFSS is an ongoing, random-digit-dialed telephone survey of the non-institutionalized 
U.S. population aged ≥18 years. BRFSS respondents who answered “yes” to the question 
“Have you ever been told by a doctor or other health professional that you have asthma?” 
were invited to participate in the ACBS. Those who consented were called back within two 
weeks and asked detailed questions about their asthma, including receipt of asthma self-
management education. Survey methodology has been described in detail elsewhere (11,12). 
The American Association for Public Opinion Research median response rates among the 31 
states and DC providing data for this report ranged from 44.0% in 2013 to 46.0% in 2014 for 
BRFSS and 46.0% in 2013 to 47.3% in 2012 for the ACBS (11,12). A surveillance 
exemption has been granted for BRFSS from the Institutional Review Board at the Centers 
for Disease Control and Prevention. Participating states are subject to their state-specific 
Institutional Review Board requirements.
Respondents who indicated they were currently “employed full time” or “employed part-
time” or had ever been employed were considered to be ever-employed. Adults with current 
asthma, WRA, and possible WRA were identified by affirmative responses to the questions 
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shown in Table 1. Persons who did not have WRA or possible WRA were considered to 
have non-WRA.
Lastly, the ACBS asks questions corresponding to the asthma self-management education 
recommendations in the NAEPP Expert Panel Report-3 (9). Respondents’ asthma self-
management education was ascertained using responses to seven questions about having 
ever been taught an asthma management course, given an action plan, taught inhaler use, 
taught to recognize early symptoms of an asthma episode, taught what to do during an 
asthma episode, taught how to use a peak flow meter, and advised to change things in their 
home, school, or work (Table 1).
Statistical analysis
Analyses were performed in 2018 using SAS version 9.4 (SAS Institute Inc., Cary, NC) and 
SUDAAN release 11.0.1 (Research Triangle Institute, Research Triangle Park, NC) survey 
procedures. Landline and cellular telephone household data for the 31 states and DC from 
2012–2014 were combined and weighted to increase reliability and precision of estimates 
and to produce estimates representative of the state populations. Weights used for analyses 
were established by multiplying the percentage of subjects in each state and survey year by 
the corresponding survey year’s weight.
The proportion of persons who received each form of asthma self-management education 
was estimated among ever employed adults with current asthma, WRA, possible WRA, and 
non-WRA. We calculated adjusted prevalence ratios (PRs) using multivariate logistic 
regression to examine whether individuals with WRA and possible WRA differed from 
those with non-WRA in the administration of asthma self-management education. Lastly, we 
examined factors associated with each form of asthma self-management education among 
individuals with WRA by fitting multivariate logistic regression models to estimate PRs. 
Age, sex, education level, household income, health insurance, and current employment 
status were significantly associated with WRA or asthma self-management education and 
were simultaneously included in all multivariate logistic regression models. Race/ethnicity 
was kept in the model regardless of statistical significance because of its importance in 
considering asthma self-management education (4). Estimates with a relative standard error 
(i.e., standard error divided by the estimate) >30% or based on a sample of <50 respondents 
were not reported (12).
Results
During 2012–2014, a total of 32,470 adults ever diagnosed with asthma participated in the 
ACBS in 31 states and DC. Of these, 23,214 (representing an estimated annual average of 15 
million persons) were ever-employed adults with current asthma. The remaining 9,256 
participants did not have current asthma (n = 8,053), were never employed (n = 462), or had 
missing data on asthma or employment status (n = 741) and were excluded from analyses.
Among ever-employed adults with current asthma, an estimated 13.9% had WRA, 39.1% 
had possible WRA, and 47.1% had non-WRA (Table 2). In bivariate analysis, receiving at 
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least one self-management education element was significantly associated with age, sex, 
household income, health insurance, and asthma status.
Overall, 98.6% of ever-employed adults with current asthma received at least one form of 
asthma self-management education. By specific form, adults with WRA were significantly 
more likely than those with non-WRA to have ever taken a course to manage their asthma 
(15.7% versus 6.5%; PR = 2.1), been given an asthma action plan (43.5% versus 26.1%; PR 
= 1.7), shown how to use an inhaler (97.2% versus 95.8%; PR = 1.0), taught how to 
recognize early symptoms of an asthma episode (79.4% versus 64.1%; PR = 1.2), taught 
what to do during an asthma episode (86.4% versus 76.3%; PR = 1.1), taught how to use a 
peak flow meter to adjust daily medications (57.9% versus 41.7%; PR = 1.3), and advised to 
change things in home, school, or work (56.9% versus 30.4%; PR = 2.0) (Table 3). Adults 
with possible WRA were significantly more likely than those with non-WRA to have ever 
taken a course to manage their asthma (10.3% versus 6.5%; PR = 1.4) and advised to change 
things in home, school, or work (38.0% versus 30.4%; PR = 1.3).
When compared with the Healthy People 2020 targets, the proportion of persons with WRA 
who received each of the seven asthma self-management education forms exceeded targets 
set for each strategy. No target was met among persons with possible WRA or non-WRA 
(Table 3).
Results from the multivariate logistic regression analyses among persons with WRA are 
shown in Table 4. Each explanatory factor was associated with at least one of the forms of 
asthma self-management education except for household income; however, no clear pattern 
was observed. Those who had very poorly controlled asthma were significantly more likely 
to have ever taken a course to manage their asthma (PR = 1.67). Those who had an asthma 
attack in the 12 months prior to the interview were more likely to have ever been given an 
asthma action plan (PR = 1.30) and been advised to change things in their home, school, or 
work (PR = 1.20). Adults who had an asthma-related emergency room visit were more likely 
to have been taught how to use a peak flow meter to adjust their medications (PR = 1.23) 
and been advised to change things in their home, school, or work (PR = 1.20). Those who 
had an overnight stay in the hospital because of their asthma were more likely to have ever 
taken a course to manage their asthma (PR = 2.11), been taught how to recognize early signs 
of an asthma episode (PR = 1.14), what to do during an asthma episode (PR = 1.09), and to 
use a peak flow meter to adjust daily medication (PR = 1.33). Those who had urgent 
treatment for worsening asthma were significantly more likely to have received all forms of 
asthma self-management education except being shown how to use an inhaler. None of the 
explanatory factors assessed were significantly associated with being shown how to use an 
inhaler. Results from the multivariate logistic regression analyses among persons with 
possible WRA are shown in the supplemental materials (Supplementary Table S1).
Lastly, we assessed the association of WRA status with adverse asthma outcomes and 
asthma control by asthma self-management education and found no differences between 
those with and without each asthma self-management education component (Supplementary 
Table S2). Adults with WRA were more likely to experience poor asthma control and 
adverse asthma outcomes compared to adults with non-WRA regardless of receipt of asthma 
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self-management education. Due to small sample sizes, however, we were unable to make 
comparison to those who received none of the seven forms of asthma self-management 
education.
Discussion
Nearly all ever-employed adults with current asthma received at least one form of asthma 
self-management education during 2012–2014. Adults with WRA were more likely to have 
ever received each of the seven asthma self-management education forms. Moreover, all 
targets set for Healthy People 2020 respiratory disease objectives RD-6 and RD-7.1–7.8 
were met only for adults with WRA (2). The greater severity of symptoms among adults 
with WRA and associated higher frequency of healthcare encounters may have resulted in 
health-care professionals being more likely to provide asthma self-management education to 
these patients to prevent asthma exacerbations and unscheduled visits (6,13).
According to the NAEPP guidelines, asthma self-management education is an integral 
component of effective asthma care and all adults with asthma should receive it (1). A web-
based educational tool has been shown to improve knowledge of WRA and self-management 
strategies, which were retained for at least one year after the study, among asthma patients in 
a tertiary care clinic (14,15). To our knowledge, however, no previous reports have assessed 
receipt of national asthma guideline recommended management at a population level among 
patients with WRA. Results of this study for persons with non-WRA are consistent with a 
previous study among adults with active asthma that indicated limited receipt of national 
asthma guideline recommended management (4).
Cloutier et al. recently reported on the uptake of the guidelines among clinicians providing 
care to asthma patients. The authors found that, although a high proportion (73–95%) of 
primary care clinicians reported providing patient education regarding asthma symptom 
recognition, avoiding risk factors, inhaler use, and changing the home/work environment, 
they did so less frequently than asthma specialists (i.e., allergists and pulmonologists; 96–
100%) (16). In this study, proportions of adults with WRA who were taught to recognize 
early symptoms of an asthma episode (79.4%), or were advised to change things in their 
home, school, or work (56.9%) are lower than would be expected based on the Cloutier et al. 
study results. Lack of healthcare providers’ knowledge about the national guidelines, 
clinician’s communication skills, lack of time during the patient visit, language barriers, 
access to specialist care, and patient health literacy and recall bias, may, in part, explain 
these differences (16–19).
Written asthma action plans are strongly recommended for patients with moderate or severe 
asthma, poorly controlled asthma, or a history of severe exacerbations, such as those with 
WRA (1,6). However, in this study, less than half of adults with WRA (43.5%) were given 
an asthma action plan. Results from the study by Cloutier et al. indicated that provision of a 
written asthma action plan was not strongly endorsed by primary care clinicians or asthma 
specialists, and may explain, in part, the low uptake (16).
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An estimated 56.9% of adults with WRA were advised to change things in their home, 
school, or work, which exceeded the corresponding Healthy People 2020 goal (54.6%) (2). 
Because eliminating or reducing work-place triggers of asthma can prevent occupational 
asthma, improve asthma symptom control, and reduce health care costs, this should be 
considered first in the management of WRA and all adults with WRA should be assessed for 
possible workplace exposures and the need for workplace intervention (7,8).
Among adults with WRA, those with poorly controlled asthma and adverse asthma 
outcomes were more likely to have received several of the asthma self-management 
education components, suggesting that greater disease severity and higher frequency of 
healthcare utilization may be associated with receipt of asthma self-management education. 
Moreover, adults with WRA were more likely to experience poor asthma control and 
adverse asthma outcomes compared to adults with non-WRA regardless of receipt of asthma 
self-management education. However, due to the cross-sectional design of the survey, we 
were unable to determine if receipt of asthma self-management education preceded or 
followed adverse asthma outcomes. Additionally, no data were available to assess if asthma 
control improved after receipt of asthma self-management education. Evidence from 
previous studies supports the use of asthma self-management education at all points of care 
and demonstrates benefits such as reductions in asthma symptoms, severe asthma 
exacerbations, healthcare utilization, and death, as well as improvements in asthma 
outcomes, quality of life, and asthma control (1,20,21).
The findings in this report are subject to additional limitations. First, information on asthma 
and self-management education was self-reported and not validated by medical records or 
follow-up with healthcare providers. Second, no information on the point of care where 
health professionals or health educators interacted with patients was available. Third, no 
information was available to explain the reason for potential missed opportunities to provide 
asthma self-management education. Finally, because data are limited to 31 states and DC, 
the results might not be nationally representative or representative of nonparticipating states.
Conclusions
Although adults with WRA were more likely to have received asthma self-management 
education, less than half received asthma action plans and approximately half were advised 
to change their home, school, or work environments to improve their asthma, suggesting 
missed opportunities to provide recommended asthma self-management education. Every 
healthcare visit should be used as an opportunity to review current asthma symptoms and 
exacerbation history, identify and remove any barriers to effective asthma self-management, 
and ensure that every patient with current asthma has an asthma action plan.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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